Mats Koeneman

Mats Koeneman

Auto-generated profile, based on publicly available information

Mats Koeneman

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Resuscitation
Verified
Journal Article
Closed access
MWMariska Weenk
Mariska Weenk
MKMats Koeneman
Mats Koeneman
TBTom H. van de Belt
Tom H. van de Belt
LELucien J.L.P.G. Engelen
Lucien J.L.P.G. Engelen
HGHarry van Goor
Harry van Goor
SBSebastian JH Bredie
Sebastian JH Bredie

10 June 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MWMariska Weenk
Mariska Weenk
SBSebastian JH Bredie
Sebastian JH Bredie
MKMats Koeneman
Mats Koeneman
GHGijs Hesselink
Gijs Hesselink
HGHarry van Goor
Harry van Goor
TBTom H van de Belt
Tom H van de Belt
Background: Wearable devices can be used for continuous patient monitoring in the general ward, increasing patient safety. Little is known about the experiences and expectations of patients and health care professionals regarding continuous monitoring with these devices.Objective: This study aimed to identify positive and negative effects as well as barriers and facilitators for the use of two wearable devices: ViSi Mobile (VM) and HealthPatch (HP).Methods: In this randomized controlled trial, 90 patients admitted to the internal medicine and surgical wards of a university hospital in the Netherlands were randomly assigned to continuous vital sign monitoring using VM or HP and a control group. Users’ experiences and expectations were addressed using semistructured interviews. Nurses, physician assistants, and medical doctors were also interviewed. Interviews were analyzed using thematic content analysis. Psychological distress was assessed using the State Trait Anxiety Inventory and the Pain Catastrophizing Scale. The System Usability Scale was used to assess the usability of both devices.Results: A total of 60 patients, 20 nurses, 3 physician assistants, and 6 medical doctors were interviewed. We identified 47 positive and 30 negative effects and 19 facilitators and 36 barriers for the use of VM and HP. Frequently mentioned topics included earlier identification of clinical deterioration, increased feelings of safety, and VM lines and electrodes. No differences related to psychological distress and usability were found between randomization groups or devices.Conclusions: Both devices were well received by most patients and health care professionals, and the majority of them encouraged the idea of monitoring vital signs continuously in the general ward. This comprehensive overview of barriers and facilitators of using wireless devices may serve as a guide for future researchers, developers, and health care institutions that consider implementing continuous monitoring in the ward.Trial Registration: Clinicaltrials.gov NCT02933307; http://clinicaltrials.gov/ct2/show/NCT02933307.

1 March 2021 in International Journal of Nursing Studies
Verified
Journal Article
Open access
YEYassin Eddahchouri
Yassin Eddahchouri
MKMats Koeneman
Mats Koeneman
MPManon Plokker
Manon Plokker
EBEgbert Brouwer
Egbert Brouwer
TBTom H van de Belt
Tom H van de Belt
SBSebastian Jh Bredie
Sebastian Jh Bredie
Periodic vital sign monitoring is commonly used to detect clinical deterioration. Incomplete assessment of Early Warning Score (EWS) and poor protocol compliance may negatively impact nurses' responsiveness to critical situations. This study assesses the quality of recorded EWSs and the degree of overall protocol compliance and protocol compliance in adverse event patients, in a centre that is an early adopter of an EWS safety protocol. Retrospective single-centre cohort study. General hospital wards of a tertiary referral university medical centre. 48,864 patients admitted to general wards between 2015 and 2018. Vital sign and Modified EWS (MEWS) data were collected from the electronic health record. MEWS completeness was evaluated by determining the proportion of missing values for each vital sign. To evaluate protocol compliance, we assessed whether the elapsed time between consecutive MEWSs was within the protocollary time as dictated by the MEWS protocol. Outcome measures were overall MEWS completeness, and both overall protocol compliance and protocol compliance specifically in the 24 h before adverse events. All required items to calculate a MEWS were present in 76 percent of the 1,663,743 vital sign measurements. Overall protocol compliance was 62 percent. For the low, mid-range and high MEWS groups, protocol compliances were 67, 47 and 30 percent, respectively. Time-to-next-MEWS exceeded protocol-recommended timing by up to 9 h for a substantial amount of MEWSs in the mid- and high-range MEWS groups. In patients with adverse events, compliance to the MEWS protocol during the 24 h prior to the events was 66 percent in aggregate, ranging from 80% in low MEWS groups, 74% in the mid-range, and 49% in the high MEWS groups. In the high MEWS group, improvements in protocol compliance were primarily noted in five hours immediately preceding the event. EWS assessments were incomplete in one-quarter of measurements. Compliance to a MEWS safety protocol was generally low, specifically when the protocol mandated more frequent MEWS assessments. Although more MEWSs were recorded in patients with adverse events, the increase in vital sign measurements' frequency mostly occurred shortly before the event manifested. This finding suggests missed opportunities to detect clinical deterioration.

8 May 2023 in Journal of Medical Systems
Verified
Journal Article
Open access
PDF file
RPRoel V. Peelen
Roel V. Peelen
YEYassin Eddahchouri
Yassin Eddahchouri
MKMats Koeneman
Mats Koeneman
RMRené Melis
René Melis
HGHarry van Goor
Harry van Goor
SBSebastian J. H. Bredie
Sebastian J. H. Bredie
To evaluate a minute-by-minute monitoring algorithm against a periodic early warning score (EWS) in detecting clinical deterioration and workload. Periodic EWSs suffer from large measurement intervals, causing late detection of deterioration. This might be prevented by continuous vital sign monitoring with a real-time algorithm such as the Visensia Safety Index (VSI). This prospective comparative data modeling cohort study (NCT04189653) compares continuous algorithmic alerts against periodic EWS in continuous monitored medical and surgical inpatients. We evaluated sensitivity, frequency, number of warnings needed to evaluate (NNE) and time of initial alert till escalation of care (EOC): Rapid Response Team activation, unplanned ICU admission, emergency surgery, or death. Also, the percentage of VSI alerting minutes was compared between patients with or without EOC. In 1529 admissions continuous VSI warned for 55% of EOC (95% CI: 45-64%) versus 51% (95% CI: 41-61%) by periodic EWS. NNE for VSI was 152 alerts per detected EOC (95% CI: 114-190) compared to 21 (95% CI: 17-28). It generated 0.99 warnings per day per patient compared to 0.13. Time from detection score till escalation was 8.3 hours (IQR: 2.6-24.8) with VSI versus 5.2 (IQR: 2.7-12.3) hours with EWS (P=0.074). The percentage of warning VSI minutes was higher in patients with EOC than in stable patients (2.36% vs 0.81%, P<0.001). Although sensitivity of detection was not significantly improved continuous vital sign monitoring shows potential for earlier alerts for deterioration compared to periodic EWS. A higher percentage of alerting minutes may indicate risk for deterioration.

19 June 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
POPaula Am Ogink
Paula Am Ogink
JJJelske M de Jong
Jelske M de Jong
MKMats Koeneman
Mats Koeneman
MWMariska Weenk
Mariska Weenk
LELucien Jlpg Engelen
Lucien Jlpg Engelen
SBSebastian JH Bredie
Sebastian JH Bredie
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Frequent home blood pressure (BP) measurements result in a better estimation of true BP. However, traditional cuff-based BP measuring is troublesome for patients. Objective: To evaluate the use and efficacy of a new cuffless device (Checkme) for ambulatory systolic blood pressure (SBP) measurement. Methods: A mixed-method study in hypertensive patients. Reliability of Checkme SBPs was analyzed quantitatively by intra-user reproducibility and comparability to a classic home BP monitor. Correct use by the patients was checked with video. Patients reported experience with qualitative semi-structured interviews and user-friendliness was assessed using a validated questionnaire. Results: 1020 Checkme SBP measurements were performed in 11 hypertensive patients. Duplicate SBPs showed a high intra-user correlation (R=0.86, p<0.01). SBP of the Checkme did not correlate well with those of the different home monitors being used (R=0.47, p<0.01). However, the mean SBP’s of the Checkme and of the home monitors over 3 weeks follow-up were highly correlated (R=0.75, p<0.01). 36.4% (n=4) of the participants performed the Checkme measurements without any mistakes. The mean SUS score was 86.4 (SD=8.3). The most important facilitator was the ease of use of the Checkme. Most important barriers included the absence of diastolic BP and the incidental difficulties in obtaining an SBP result. Conclusions: Given the good intra-user reproducibility, user-friendliness and patient experience, which all facilitate patients to perform frequent measurements, cuffless BP monitoring may change the way patients are measuring their home BP in the context of ambulant hypertension management. Clinical Trial: NA

24 June 2021 in Shock
Verified
Journal Article
Closed access
MKMats Koeneman
Mats Koeneman
RKRebecca Koch
Rebecca Koch
HGHarry van Goor
Harry van Goor
PPPeter Pickkers
Peter Pickkers
MKMatthijs Kox
Matthijs Kox
SBSebastian Bredie
Sebastian Bredie
Introduction: Early diagnosis and treatment can reduce the risk of organ failure and mortality in systemic inflammatory conditions. Heart rate variability (HRV) has potential for early identification of the onset of systemic inflammation, as it may detect changes in sympathetic nervous system activity resulting from the developing inflammatory response before clinical signs appear. With the use of new methodologies, we investigated the onset and kinetics of HRV changes as well as several inflammatory parameters and symptoms during experimental human endotoxemia, a model of systemic inflammation in humans in vivo. Patients and Methods: Healthy volunteers were intravenously administered LPS (n = 15) or placebo (n = 15). HRV was determined using a wireless wearable device, and parameters low to high frequency (LF:HF) ratio, root mean square of the successive differences (RMSSD), and standard deviation of normal-to-normal R-R intervals (SDNN)were calculated through 1-min-rolling 6-min windows. Plasma cytokine levels and flu-like symptoms and vital signs were serially assessed. Results: The increase in LF:HF ratio, reflecting sympathetic predominance, was more pronounced in the LPS group compared to the placebo group, with the difference becoming statistically significant 65 min following LPS administration (1.63 [1.42–1.83] vs. 1.28 [1.11–1.44], P = 0.005). Significant between-group differences in RMSSD and SDNN were observed from 127 to 140 min post-LPS administration onwards, respectively. Plasma cytokine levels showed significant between-group differences staring 60 min post-LPS. For symptom score, heart rate, temperature, and diastolic blood pressure, significant differences compared with the placebo group were observed at 90, 118, 120, and 124 min post-LPS, respectively. Conclusion: In a controlled human model of systemic inflammation, elevations in the LF:HF ratio followed very shortly after elevations in plasma cytokine levels and preceded onset of flu-like symptoms and alterations in vital signs. HRV may represent a promising non-invasive tool for early detection of a developing systemic inflammatory response.